Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Nav1.8 Antikörper (C-Term)

SCN10A Reaktivität: Ratte IHC, WB, FM Wirt: Maus Monoclonal S134-12 unconjugated
Produktnummer ABIN6658124
  • Target Alle Nav1.8 (SCN10A) Antikörper anzeigen
    Nav1.8 (SCN10A) (Sodium Channel, Voltage-Gated, Type X, alpha Subunit (SCN10A))
    Bindungsspezifität
    • 12
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 17
    • 16
    • 3
    • 1
    Ratte
    Wirt
    • 17
    • 13
    • 1
    • 1
    Maus
    Klonalität
    • 19
    • 13
    Monoklonal
    Konjugat
    • 12
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Nav1.8 Antikörper ist unkonjugiert
    Applikation
    • 18
    • 18
    • 15
    • 12
    • 10
    • 7
    • 2
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), Western Blotting (WB), Fluorescence Microscopy (FM)
    Kreuzreaktivität
    Human, Maus, Ratte (Rattus)
    Aufreinigung
    Anti-NAV1.8 Antibody was purified by Protein G chromatography. A BLAST analysis was used to suggest cross-reactivity with NAV1.8 from human, mouse, and rat based on 100% homology with the immunizing sequence. No cross reactivity against other Nav channels. Cross-reactivity with NAV1.8 from other sources has not been determined. Ion Channels research.
    Immunogen

    Immunogen: Nav1.8 Antibody was produced in mice by repeated immunizations raised against a fusion protein corresponding near the cytoplasmic C-terminus region of rat Nav1.8.

    Immunogen Type: Recombinant Protein

    Klon
    S134-12
    Isotyp
    IgG2a
    Top Product
    Discover our top product SCN10A Primärantikörper
  • Applikationshinweise

    Immunohistochemistry Dilution: 0.1-1.0 μg/mL

    Application Note: Anti-NAV1.8 Antibody is suitable for use in WB, IHC and IF microscopy. Expect a band approximately ~220 kDa on specific lysates. Specific conditions for reactivity should be optimized by the end user.

    Western Blot Dilution: 1-10 μg/mL

    IF Microscopy Dilution: 1.0-10 μg/mL

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: 50 % (v/v) Glycerol

    0.09 % (w/v) Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    RT,4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
  • Target
    Nav1.8 (SCN10A) (Sodium Channel, Voltage-Gated, Type X, alpha Subunit (SCN10A))
    Andere Bezeichnung
    NAV1.8 (SCN10A Produkte)
    Synonyme
    Nav1.8 antikoerper, PN3 antikoerper, SNS antikoerper, hPN3 antikoerper, Na(V)1.8 antikoerper, sodium channel, voltage-gated, type X, alpha antikoerper, sodium voltage-gated channel alpha subunit 10 antikoerper, Scn10a antikoerper, SCN10A antikoerper
    Hintergrund

    Synonyms: PN3, Na(V)1.8, Scn10a, Sodium channel protein type 10 subunit alpha, Peripheral nerve sodium channel 3, Sensory neuron sodium channel, Sodium channel protein type X subunit alpha, Voltage-gated sodium channel subunit alpha Nav1.8

    Background: Nav1.8 is a voltage-gated sodium channel and plays a critical role in the generation and conduction of action potentials and is thus important for electrical signaling by most excitable cells. Therapeutically, the association of pain insensitivity with the loss of function of a certain sodium channel may have implications. Since Nav1.8 is not present in cardiac muscle or neurons in the central nervous system, blockers of Nav1.8 will not have direct action on these cells and thus can have less side effects than current pain medications. By performing more studies, there is a possibility to develop a new generation of drugs that can reduce the pain intensity in animals.

    Gene Name: Scn10a

    Gen-ID
    29571
    NCBI Accession
    NP_058943
    UniProt
    Q62968
Sie sind hier:
Kundenservice